Briarcliff Manor, NY, United States of America

Naga Suhasini Avvaru

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naga Suhasini Avvaru. Retrieved from https://idiyas.com/inventor/naga-suhasini-avvaru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naga Suhasini Avvaru: Innovator in Binding Molecules

Introduction

Naga Suhasini Avvaru is a notable inventor based in Briarcliff Manor, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules. His work is recognized for its potential applications in therapeutic methods.

Latest Patents

Naga Suhasini Avvaru holds a patent for "CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF." This patent represents a significant advancement in the understanding and application of binding molecules in medical treatments. He has 1 patent to his name, showcasing his innovative approach to solving complex biological challenges.

Career Highlights

Naga Suhasini Avvaru is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its focus on developing medicines for serious diseases. His role at Regeneron allows him to work at the forefront of scientific research and innovation.

Collaborations

Throughout his career, Naga has collaborated with esteemed colleagues, including Bei Wang and Chia-Yang Lin. These collaborations have contributed to the advancement of research and development in their respective fields.

Conclusion

Naga Suhasini Avvaru is a distinguished inventor whose work in binding molecules has the potential to impact therapeutic methods significantly. His contributions to biotechnology and his collaborations with other experts highlight his commitment to innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…